ncRNA name
HEIH
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-98-5p/PI3K/AKT
Cancer name
Hepatocellular Carcinoma
Cancer site
qRT-PCR,Western blot,Dual-luciferase assay
Treatment type
Chemotherapy
Drug
Sorafenib
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway
Tissue resource
hepatocellular carcinoma tissues
hepatocellular carcinoma cell lines HCCLM3
hepatocellular carcinoma cell lines Huh7
Experiment
None
Institute
Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai Academy of Life Science
Country
China
China
Continent
Asia
Asia